8.05
前日終値:
$8.15
開ける:
$8.1
24時間の取引高:
163.60K
Relative Volume:
0.91
時価総額:
$77.28M
収益:
$24.99M
当期純損益:
$-118.64M
株価収益率:
-6.145
EPS:
-1.31
ネットキャッシュフロー:
$-100.25M
1週間 パフォーマンス:
+1.51%
1か月 パフォーマンス:
-5.82%
6か月 パフォーマンス:
-17.11%
1年 パフォーマンス:
-53.84%
Adicet Bio Inc Stock (ACET) Company Profile
ACET を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ACET
Adicet Bio Inc
|
8.05 | 78.24M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-30 | 再開されました | Guggenheim | Buy |
| 2024-09-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-06-27 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 開始されました | JP Morgan | Overweight |
| 2022-03-31 | 開始されました | SMBC Nikko | Outperform |
| 2022-03-08 | 開始されました | Truist | Buy |
| 2022-03-04 | 開始されました | Jefferies | Buy |
| 2021-05-18 | 開始されました | BTIG Research | Buy |
| 2021-04-23 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-14 | 開始されました | Canaccord Genuity | Buy |
| 2021-04-08 | 開始されました | Guggenheim | Buy |
| 2020-11-04 | 開始されました | B. Riley Securities | Buy |
| 2020-10-27 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-16 | 開始されました | Wedbush | Outperform |
すべてを表示
Adicet Bio Inc (ACET) 最新ニュース
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment - Benzinga
Canaccord Genuity lowers Adicet Bio stock price target to $18 from $128 - Investing.com
Adicet Bio (NASDAQ:ACET) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Adicet Bio (NASDAQ:ACET) Shares Up 4.5%What's Next? - MarketBeat
Adicet Bio implements reverse stock split to maintain listing - MSN
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - MarketBeat
Adicet Bio Implements Reverse Stock Split to Maintain Listing - TipRanks
Adicet Bio Announces Reverse Stock Split - marketscreener.com
Adicet Bio announces one-for-16 reverse stock split - MSN
Adicet Bio Stock Scheduled to Reverse Split on Tuesday, December 30th (NASDAQ:ACET) - MarketBeat
What's Going On With Adicet Bio Stock Today? - Benzinga
Adicet Bio To Implement 1-for-16 Reverse Stock Split On December 30 - Nasdaq
Adicet Bio to implement 1-for-16 reverse stock split By Investing.com - Investing.com Nigeria
Adicet Bio slides after announcing one-for-16 reverse stock split - TradingView — Track All Markets
Adicet Bio announces reverse stock split - marketscreener.com
Adicet Bio to implement 1-for-16 reverse stock split - Investing.com
Adicet Bio stock falls after announcing 1-for-16 reverse split - Investing.com Canada
Adicet Bio slides after announcing one-for-16 stock split - TradingView — Track All Markets
Adicet Bio Announces 1-for-16 Reverse Stock Split; Shares Fall Pre-Bell - marketscreener.com
Biotech shrinks share count 16 to 1—what changes for its shareholders - Stock Titan
Adicet Bio (NASDAQ:ACET) Shares Cross Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
CEO Moves: Can Adicet Bio Inc 1IJA stock hold up in economic slowdownJuly 2025 Market Mood & Reliable Volume Spike Alerts - moha.gov.vn
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Target Price at $7.33 - Defense World
Will Adicet Bio Inc. stock recover faster than peersEarnings Overview Summary & Growth Focused Entry Reports - Улправда
Can Adicet Bio Inc. stock sustain revenue growthWeekly Investment Recap & Reliable Volume Spike Trade Alerts - Улправда
Adicet Bio Shareholders Approve Flexible Reverse Stock Split - TipRanks
Why Adicet Bio Inc. stock remains a top recommendation2025 Trading Recap & Accurate Buy Signal Alerts - DonanımHaber
Is Adicet Bio Inc. stock a smart buy before Fed meetingWeekly Market Outlook & Free Safe Capital Growth Stock Tips - Улправда
How Adicet Bio Inc. stock reacts to Fed rate cuts2025 Market WrapUp & Risk Controlled Swing Alerts - Bölüm Sonu Canavarı
Market Wrap: Is Adicet Bio Inc. stock a smart buy before Fed meetingSwing Trade & Detailed Earnings Play Alerts - Улправда
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Adicet Bio reports progress in clinical trial enrollments - MSN
Nothing is Better Than Adicet Bio Inc (ACET) stock at the moment - setenews.com
Adicet Bio price target raised to $9 from $4 at H.C. Wainwright - MSN
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
What dividend safety rating applies to Adicet Bio Inc. (1IJA) stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - Newser
Retail Trends: How Adicet Bio Inc stock trades during market volatilityBond Market & Low Drawdown Momentum Trade Ideas - moha.gov.vn
How higher bond yields impact Adicet Bio Inc. (1IJA) stockJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Can Adicet Bio Inc. (1IJA) stock sustain breakout momentumTrade Risk Summary & Real-Time Chart Pattern Alerts - Newser
Is Adicet Bio Inc. (1IJA) stock bottoming after sell offJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
Why Adicet Bio Inc. (1IJA) stock remains top ratedJuly 2025 Selloffs & Short-Term High Return Ideas - Newser
What analyst consensus implies for Adicet Bio Inc. (1IJA) stockJuly 2025 Breakouts & Fast Entry Momentum Alerts - Newser
Adicet Bio (ACET) Stock Analysis Report | Financials & Insights - Benzinga
Views of Wall Street’s Leading Experts on Adicet Bio Inc - setenews.com
Is Adicet Bio Inc. (1IJA) stock prepared for digital transitionTrade Volume Summary & Growth Focused Stock Reports - Newser
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Adicet Bio (Nasdaq: ACET) issues options for 20,600 shares at $0.65 exercise price - Stock Titan
Adicet Bio receives FDA fast track designation for its lupus erythematosus treatment - MSN
Perhaps timely catching Adicet Bio Inc (ACET) would be a good idea - Setenews
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $7.33 - Defense World
Adicet Bio (ACET) Price Target Increased by 20.00% to 7.75 - MSN
Adicet Bio Inc (ACET) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):